Last10K.com

Canopy Growth Corp (CGC) SEC Filing 10-K Annual Report for the fiscal year ending Wednesday, March 31, 2021

SEC Filings

Canopy Growth Corp

CIK: 1737927 Ticker: CGC

 

Exhibit 99.1

 

CANOPY GROWTH REPORTS FOURTH QUARTER AND FISCAL YEAR 2021 FINANCIAL RESULTS

 

Achieves 37% revenue growth in FY 2021 with strong double-digit growth across both cannabis and other consumer products businesses

Improved supply chain execution and quality enhancements are leading to commercial success

Maintains #1 market share1 of the total flower category in Canada; recently announced acquisitions further solidify Canopy’s leadership position in the Canadian recreational market    

The U.S. ecosystem strategy continues to gain traction with focus to further capitalize on growth opportunities in the U.S.

Remains on track to achieve positive Adjusted EBITDA during the second half of FY 2022

June 1, 2021

SMITHS FALLS, ON — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NASDAQ:CGC) today announces its financial results for the fourth quarter and Fiscal Year 2021 ended March 31, 2021.  All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.

“During Fiscal 2021, Canopy Growth transformed into a CPG-modelled organization, reinforcing a foundation for sustained growth and long-term success. By leveraging consumer insights and innovation to deliver best-in-class products, Canopy Growth is positioned to achieve our goal of unleashing the power of cannabis to improve lives," said David Klein, CEO, Canopy Growth. “We are starting to see strong momentum across all of our key businesses and remain firmly focused on capitalizing on U.S. opportunities in Fiscal 2022.”

“We made tremendous progress improving our supply chain and right-sizing our manufacturing footprint, bringing supply and demand into balance,” added Mike Lee, CFO. “Our cost savings program is on track to deliver $150-$200 million of savings within the next 18 months, and we remain committed to our path to profitability by the end of Fiscal 2022, while continuing to invest in an organization that is focused on insights, innovation and gaining momentum in the U.S. market.”

 

 

1 

Unless otherwise indicated, market share data disclosed in this press release is calculated using the Company’s internal proprietary market share tool that utilizes point of sales data supplied by a third-party data provider, government agencies and our own retail store operations across the country.  Tool captures point of sale data from an average of 29% of stores in Alberta, British Columbia, Saskatchewan, Manitoba and Newfoundland & Labrador, point of sale data from 100% of stores in New Brunswick, Nova Scotia and Prince Edward Island, as well as depletions and ecommerce sales data from the OCS.

 

 


The following information was filed by Canopy Growth Corp (CGC) on Tuesday, June 1, 2021 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Canopy Growth Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Canopy Growth Corp.

Continue

Assess how Canopy Growth Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Canopy Growth Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
M & A
Revenue
Legal
Other
Filter Subcategory:
All
Shares
Income
Expense
Cash Flow
Earnings
Product
Geography
Debt
Other
Inside Canopy Growth Corp's 10-K Annual Report:

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Operations And Comprehensive Loss
Consolidated Statements Of Shareholders' Equity
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss) (Tables)
Accumulated Other Comprehensive Income (Loss) - Accumulated Other Comprehensive Income (Details)
Acquisitions
Acquisitions (Tables)
Acquisitions - Acquisition Of Noncontrolling Shareholder's Interest In Bc Tweed (Details)
Acquisitions - Additional Information (Details)
Acquisitions - Bct And Spectrum Uk - Additional Information (Details)
Acquisitions - Bct And Spectrum Uk - Summary Of Measurement Period Adjustments (Details)
Acquisitions - Biostee - Summary Of Measurement Period Adjustments (Details)
Acquisitions - Biosteel - Additional Information (Details)
Acquisitions - C3 - Additional Information (Details)
Acquisitions - C3 - Summary Of Measurement Period Adjustments (Details)
Acquisitions - Chi - Additional Information (Details)
Acquisitions - Ebbu - Additional Information (Details)
Acquisitions - Hiku - Additional Information (Details)
Acquisitions - Pos - Additional Information (Details)
Acquisitions - S&Amp;B - Additional Information (Details)
Acquisitions - Summary Of Consolidated Balance Sheet Impact At Acquisition Of Company's Business Combinations (Details)
Acquisitions - This Works - Additional Information (Details)
Acquisitions - This Works - Summary Of Measurement Period Adjustments (Details)
Acreage Arrangement And Amendments To Cbi Investor Rights Agreement And Warrants
Acreage Arrangement And Amendments To Cbi Investor Rights Agreement And Warrants - Additional Information (Details)
Amounts Receivable, Net
Amounts Receivable, Net (Tables)
Amounts Receivable, Net - Additional Information (Details)
Amounts Receivable, Net - Components Of Amounts Receivable, Net (Details)
Asset Impairment And Restructuring Costs
Asset Impairment And Restructuring Costs (Tables)
Asset Impairment And Restructuring Costs - Additional Information (Details)
Asset Impairment And Restructuring Costs - Summary Of Pre-Tax Charges Recognized In Restructuring Actions And Other Impairments (Details)
Basis Of Presentation
Cash And Cash Equivalents
Cash And Cash Equivalents (Tables)
Cash And Cash Equivalents - Components Of Cash And Cash Equivalents (Details)
Commitments
Commitments (Tables)
Commitments - Summary Of Annual Minimum Commitments Associated With Contractual Agreements (Details)
Debt
Debt (Tables)
Debt - Additional Information (Details)
Debt - Summary Of Components Of Debt (Details)
Debt - Summary Of Components Of Debt (Parenthetical) (Details)
Debt - Summary Of Required Principal Repayments Under Long-Term Debt Obligations (Details)
Description Of Business
Equity Method Investments
Equity Method Investments (Tables)
Equity Method Investments - Agripharm - Additional Information (Details) - Agripharm
Equity Method Investments - Canapar - Additional Information (Details)
Equity Method Investments - Chi And Bct - Additional Information (Details)
Equity Method Investments - More Life - Additional Information (Details)
Equity Method Investments - Summary Of Changes In Investments In Associates That Are Accounted For Using Equity Method (Details)
Equity Method Investments - Summary Of Derecognized Assets And Liabilities (Details)
Equity Method Investments - Summary Of Financial Information Of Equity Method Investments (Details)
Fair Value Of Financial Instruments
Fair Value Of Financial Instruments (Tables)
Fair Value Of Financial Instruments - Summary Of Financial Assets And Liabilities Measured At Estimated Fair Value On A Recurring Basis (Details)
Fair Value Of Financial Instruments - Summary Of Valuation Techniques And Significant Unobservable Inputs In The Fair Value Measurement Of Significant Level 2 Financial Instruments (Details)
Fair Value Of Financial Instruments - Summary Of Valuation Techniques And Significant Unobservable Inputs In The Fair Value Measurement Of Significant Level 3 Financial Instruments (Details)
Goodwill
Goodwill (Tables)
Goodwill - Changes In Carrying Amount Of Goodwill (Details)
Income Taxes
Income Taxes (Tables)
Income Taxes - Additional Information (Details)
Income Taxes - Summary Of Income Tax Recovery (Expense) (Details)
Income Taxes - Summary Of Losses Carried Forward Available To Reduce Future Years' Taxable Income (Details)
Income Taxes - Summary Of Net Loss Before Income Taxes (Details)
Income Taxes - Summary Of Reconciliation Of Amount Of Income Taxes Compared To Expected Income Taxes Calculated At Combined Federal And Provincial Enacted Statutory Tax Rate (Details)
Income Taxes - Summary Of Significant Compenents Of Deferred Income Tax Assets (Liabilities) (Details)
Income Taxes - Summary Of Significant Compenents Of Deferred Income Tax Assets (Liabilities) (Parenthetical) (Details)
Intangible Assets
Intangible Assets (Tables)
Intangible Assets - Additional Information (Details)
Intangible Assets - Summary Of Components Of Intangible Assets (Details)
Intangible Assets - Summary Of Estimated Amortization Expense (Details)
Inventory
Inventory (Tables)
Inventory - Additional Information (Details)
Inventory - Components Of Inventory (Details)
Leases
Leases (Tables)
Leases - Additional Information (Details)
Leases - Summary Of Components Of Total Lease Expense (Details)
Leases - Summary Of Future Lease Expense For Operating Leases (Details)
Leases - Summary Of Lease Right-Of-Use Assets And Liabilities (Details)
Leases - Summary Of Measurement Of Lease Liabilities (Details)
Leases - Summary Of Minimum Payments Due For Lease Liabilities (Details)
Leases - Summary Of Right-Of-Use Assets Obtained In Exchange For New Lease Liabilities (Details)
Leases - Summary Of Weighted Average Discount Rate (Details)
Leases - Summary Of Weighted Average Remaining Lease Term (Details)
New Accounting Policies
Noncontrolling Interests
Noncontrolling Interests (Tables)
Noncontrolling Interests - Summary Of Net Change In Noncontrolling Interests (Details)
Other Accrued Expenses And Liabilities
Other Accrued Expenses And Liabilities (Tables)
Other Accrued Expenses And Liabilities - Components Of Other Accrued Expenses And Liabilities (Details)
Other Financial Assets
Other Financial Assets (Tables)
Other Financial Assets - Additional Information (Details)
Other Financial Assets - Summary Of Changes In Other Financial Assets (Details)
Other Income (Expense), Net
Other Income (Expense), Net (Tables)
Other Income (Expense), Net - Schedule Of Other Income (Expense), Net (Details)
Other Liabilities
Other Liabilities (Tables)
Other Liabilities - Additional Information (Details)
Other Liabilities - Components Of Other Liabilities (Details)
Pharmhouse
Pharmhouse - Additional Information (Details)
Pharmhouse - Other Financial Assets, Including Loans Receivable - Additional Information (Details)
Pharmhouse - Pharmhouse Equity Method Investment - Additional Information (Details)
Pharmhouse - Pharmhouse Financial Guarantee - Additional Information (Details)
Plan Of Arrangement With Riv Capital
Plan Of Arrangement With Riv Capital (Tables)
Plan Of Arrangement With Riv Capital - Additional Information (Details)
Plan Of Arrangement With Riv Capital - Schedule Of Derecognized Assets And Liabilities (Details)
Prepaid Expenses And Other Assets
Prepaid Expenses And Other Assets (Tables)
Prepaid Expenses And Other Assets - Components Of Prepaid And Other Assets (Details)
Property, Plant And Equipment
Property, Plant And Equipment (Tables)
Property, Plant And Equipment - Additional Information (Details)
Property, Plant And Equipment - Schedule Of Components Of Property, Plant And Equipment (Details)
Redeemable Noncontrolling Interest
Redeemable Noncontrolling Interest (Tables)
Redeemable Noncontrolling Interest - Summary Of Net Change In Redeemable Noncontrolling Interests (Details)
Related Party
Related Party - Additional Information (Details)
Revenue
Revenue (Tables)
Revenue - Additional Information (Details)
Revenue - Summary Of Disaggregation Of Revenue (Details)
Revenue - Summary Of Disaggregation Of Revenue (Parenthetical) (Details)
Segmented Information
Segmented Information (Tables)
Segmented Information - Additional Information (Details)
Segmented Information - Summary Of Disaggregation Of Long-Lived Tangible Assets By Geographic Areas (Details)
Segmented Information - Summary Of Disaggregation Of Net Revenue By Geographic Area (Details)
Segmented Information - Summary Of Reconciliation Of Operating Profit (Loss) From Segments To Consolidated (Details)
Selected Quarterly Financial Information (Unaudited)
Selected Quarterly Financial Information (Unaudited) (Tables)
Selected Quarterly Financial Information (Unaudited) - Summary Of Selected Quarterly Financial Information (Details)
Share Capital
Share Capital (Tables)
Share Capital - Additional Information (Details)
Share Capital - Summary Of Assets Acquired And Liabilities Assumed At Fair Value (Details)
Share Capital - Summary Of Issuances Of Stock Other (Details)
Share Capital - Summary Of Warrants (Details)
Share-Based Compensation
Share-Based Compensation (Tables)
Share-Based Compensation - Additional Information (Details)
Share-Based Compensation - Summary Of Assumptions Applied To Establish Fair Value Of Options Granted Using Black-Scholes Option Pricing Model (Details)
Share-Based Compensation - Summary Of Change In Seed Capital Options (Details)
Share-Based Compensation - Summary Of Changes In Riv Capital's Stock Options (Details)
Share-Based Compensation - Summary Of Changes In Rsus (Details)
Share-Based Compensation - Summary Of Outstanding Stock Options (Details)
Share-Based Compensation - Summary Of Share-Based Compensation Expense Related To Acquisition Milestones (Details)
Share-Based Compensation - Summary Of The Changes In Omnibus Plan Employee Options (Details)
Short-Term Investments
Short-Term Investments (Tables)
Short-Term Investments - Additional Information (Details)
Short-Term Investments - Components Of Short-Term Investments (Details)
Subsequent Events
Subsequent Events - Additional Information (Details)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies (Tables)
Summary Of Significant Accounting Policies - Additional Information (Details)
Summary Of Significant Accounting Policies - Summary Of Expected Useful Life Of Property, Plant And Equipment (Details)
Summary Of Significant Accounting Policies - Summary Of Finite Lived Intangible Assets Useful Life (Details)
Ticker: CGC
CIK: 1737927
Form Type: 10-K Annual Report
Accession Number: 0001564590-21-031214
Submitted to the SEC: Tue Jun 01 2021 5:21:32 PM EST
Accepted by the SEC: Tue Jun 01 2021
Period: Wednesday, March 31, 2021
Industry: Medicinal Chemicals And Botanical Products

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/cgc/0001564590-21-031214.htm